GlassScriptPhysician profile
Lisette Delgado Sanchez
NPI 1558523050
$32,360.80
in general payments reported to CMS, 2019-2025
54 companies · $9,448 in 2025
The $9,448 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,534 · 2020: $2,590 · 2021: $2,562 · 2022: $3,773 · 2023: $4,462 · 2024: $5,992 · 2025: $9,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Consulting Fee: $4,677 · Education: $363 · Travel and Lodging: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,727.71 |
| Consulting Fee | $4,677.00 |
| Education | $362.76 |
| Travel and Lodging | $134.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $6,080.19 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $5,281.23 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $3,055.74 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Actelion Pharmaceuticals US, INC. | $2,322.45 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,208.60 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $2,021.03 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $1,453.71 | 2019-2025 | Prolastin-C Liquid |
| Insmed, INC. | $1,157.89 | 2019-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $1,105.03 | 2020-2025 | Glassia, Cuvitru, Hyqvia |
| United Therapeutics Corporation | $758.96 | 2019-2025 | Tyvaso, Tyvaso, Remodulin |
| Mallinckrodt Hospital Products INC. | $702.68 | 2020-2025 | Acthar |
| Mylan Specialty L.P. | $471.76 | 2019-2024 | Yupelri |
| Electromed, INC. | $447.79 | 2019-2025 | Smartvest |
| Philips North America LLC | $447.04 | 2019-2025 | Vest Therapy Und |
| Genentech USA, INC. | $436.42 | 2019-2024 | Xolair |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $423.66 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $388.66 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $369.59 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $335.77 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $324.98 | 2021-2025 | Winrevair, Zerbaxa, Dificid |
| Amgen INC. | $272.16 | 2022-2025 | Tezspire, Tavneos |
| Baxter Healthcare | $230.76 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Boston Scientific Corporation | $206.80 | 2023-2025 | Farapulse, Watchman Flx |
| Paratek Pharmaceuticals, INC. | $195.21 | 2020-2025 | Nuzyra |
| Verona Pharma, INC. | $190.12 | 2025 | Ohtuvayre |
| Ethicon INC. | $181.68 | 2019 | |
| Inspire Medical Systems, INC. | $155.39 | 2023-2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $128.95 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $123.82 | 2021-2022 | |
| Advanced Respiratory, INC | $108.87 | 2019 | |
| Viatris Specialty LLC | $90.87 | 2025 | Yupelri |
| Pfizer INC. | $56.65 | 2019-2025 | |
| Harmony Biosciences LLC | $55.91 | 2024 | |
| Resmed Corp | $54.19 | 2019-2022 | |
| Veran Medical Technologies, INC. | $48.37 | 2020-2021 | |
| Novo Nordisk INC | $46.14 | 2024 | Wegovy |
| Circassia INC. | $44.69 | 2019-2020 | |
| Covis Pharma Gmbh | $42.42 | 2021 | |
| Nabriva Therapeutics, Plc | $40.46 | 2022 | |
| Shire North American Group INC | $38.72 | 2019 | |
| Azurity Pharmaceuticals, INC. | $36.53 | 2025 | Alvesco |
| Avadel Cns Pharmaceuticals, LLC | $28.31 | 2024 | Lumryz |
| Inogen, INC. | $24.40 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Axsome Therapeutics, INC. | $22.92 | 2024 | Sunosi |
| Mallinckrodt Enterprises LLC | $21.32 | 2019 | |
| La Jolla Pharmaceutical Company | $19.45 | 2019 | |
| Axonics, INC. | $19.43 | 2024 | Axonics |
| Teva Pharmaceuticals USA, INC. | $19.37 | 2021 | |
| Pulmonx Corporation | $18.07 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Kaleo, INC. | $16.22 | 2021 | |
| Abbvie INC. | $15.00 | 2024 | |
| Lilly USA, LLC | $14.42 | 2025 | Zepbound |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisette Delgado Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.